ARL2BP | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	16 studies	26% ± 11%	Explore
fibroblast	15 studies	24% ± 9%	Explore
CD4-positive, alpha-beta T cell	12 studies	21% ± 5%	Explore
natural killer cell	12 studies	21% ± 4%	Explore
endothelial cell of artery	10 studies	21% ± 6%	Explore
smooth muscle cell	10 studies	20% ± 5%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	9 studies	21% ± 5%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	21% ± 2%	Explore
gamma-delta T cell	9 studies	22% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	8 studies	20% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	22% ± 4%	Explore
capillary endothelial cell	8 studies	21% ± 3%	Explore
CD8-positive, alpha-beta T cell	8 studies	23% ± 6%	Explore
connective tissue cell	7 studies	26% ± 7%	Explore
pericyte	7 studies	21% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	22% ± 4%	Explore
B cell	6 studies	19% ± 3%	Explore
mature NK T cell	6 studies	18% ± 2%	Explore
T cell	6 studies	21% ± 6%	Explore
myofibroblast cell	6 studies	21% ± 2%	Explore
mucosal invariant T cell	6 studies	18% ± 2%	Explore
endothelial cell of vascular tree	6 studies	18% ± 3%	Explore
oligodendrocyte precursor cell	6 studies	32% ± 6%	Explore
memory B cell	6 studies	18% ± 1%	Explore
neuron	5 studies	26% ± 16%	Explore
epithelial cell	5 studies	36% ± 14%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	23% ± 3%	Explore
classical monocyte	4 studies	25% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	19% ± 4%	Explore
ciliated cell	4 studies	33% ± 12%	Explore
abnormal cell	4 studies	32% ± 14%	Explore
type I pneumocyte	4 studies	21% ± 5%	Explore
glutamatergic neuron	4 studies	31% ± 15%	Explore
oligodendrocyte	4 studies	19% ± 2%	Explore
naive B cell	4 studies	17% ± 1%	Explore
type B pancreatic cell	3 studies	28% ± 9%	Explore
conventional dendritic cell	3 studies	33% ± 12%	Explore
non-classical monocyte	3 studies	31% ± 5%	Explore
glomerular endothelial cell	3 studies	19% ± 2%	Explore
retina horizontal cell	3 studies	22% ± 6%	Explore
regulatory T cell	3 studies	18% ± 2%	Explore
mesothelial cell	3 studies	32% ± 24%	Explore
macrophage	3 studies	21% ± 3%	Explore
GABAergic neuron	3 studies	29% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	23% ± 7%	Explore
vein endothelial cell	3 studies	20% ± 2%	Explore
group 3 innate lymphoid cell	3 studies	21% ± 6%	Explore
erythroblast	3 studies	31% ± 19%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	10 studies	20% ± 4%	Explore
brain	6 studies	23% ± 8%	Explore
lung	4 studies	27% ± 6%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	99%	95.45	1434 / 1445	92%	2.99	169 / 183
ovary	100%	92.23	180 / 180	83%	2.07	355 / 430
stomach	97%	55.96	348 / 359	71%	1.82	202 / 286
intestine	99%	91.68	961 / 966	50%	1.52	265 / 527
brain	98%	85.63	2585 / 2642	48%	1.25	341 / 705
kidney	100%	75.69	89 / 89	32%	0.64	292 / 901
bladder	100%	89.95	21 / 21	30%	0.84	150 / 504
lung	98%	83.01	568 / 578	30%	0.57	347 / 1155
uterus	99%	110.69	169 / 170	27%	0.47	122 / 459
skin	99%	123.59	1795 / 1809	25%	0.45	120 / 472
adrenal gland	93%	48.93	239 / 258	30%	0.54	69 / 230
breast	100%	97.79	458 / 459	18%	0.29	201 / 1118
pancreas	87%	30.20	286 / 328	29%	0.46	52 / 178
prostate	99%	62.64	242 / 245	15%	0.21	74 / 502
thymus	99%	65.40	647 / 653	13%	0.22	81 / 605
adipose	100%	103.82	1202 / 1204	0%	0	0 / 0
blood vessel	99%	90.57	1328 / 1335	0%	0	0 / 0
spleen	98%	46.91	235 / 241	0%	0	0 / 0
muscle	92%	40.57	741 / 803	0%	0	0 / 0
heart	92%	59.01	790 / 861	0%	0	0 / 0
peripheral blood	78%	45.72	721 / 929	0%	0	0 / 0
liver	38%	10.68	86 / 226	5%	0.07	20 / 406
lymph node	0%	0	0 / 0	41%	1.19	12 / 29
eye	0%	0	0 / 0	38%	0.62	30 / 80
tonsil	0%	0	0 / 0	22%	0.41	10 / 45
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0007165	Biological process	signal transduction
GO_0042531	Biological process	positive regulation of tyrosine phosphorylation of STAT protein
GO_0051457	Biological process	maintenance of protein location in nucleus
GO_0045893	Biological process	positive regulation of DNA-templated transcription
GO_0005813	Cellular component	centrosome
GO_0005758	Cellular component	mitochondrial intermembrane space
GO_0005929	Cellular component	cilium
GO_0005654	Cellular component	nucleoplasm
GO_0005829	Cellular component	cytosol
GO_0030496	Cellular component	midbody
GO_0005759	Cellular component	mitochondrial matrix
GO_0005819	Cellular component	spindle
GO_0030695	Molecular function	GTPase regulator activity
GO_0003713	Molecular function	transcription coactivator activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	ARL2BP
Protein name	ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) (ARL2-binding protein) (Binder of ARF2 protein 1)
Synonyms	BART BART1
Description	FUNCTION: Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2. . FUNCTION: Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2. . FUNCTION: Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2. .
Accessions	Q9Y2Y0 H3BU49 H3BM52 ENST00000219204.8 [Q9Y2Y0-1] ENST00000562023.5 ENST00000563234.1

ARL2BP report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review